Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akseli Hemminki

Showing results (151-160 of 280) with videos related to

Pageof 28
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearanceVincenzo Cerullo, Iulia Diaconu, Valentina Romano, et al.
Plos One|January 26, 2013
MicroRNA-mediated suppression of oncolytic adenovirus replication in human liverErkko Ylösmäki, Sergio Lavilla-Alonso, Sari Jäämaa, et al.
Cancer Immunology Research|May 16, 2015
Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the TumorSiri Tähtinen, Susanna Grönberg-Vähä-Koskela, Dave Lumen, et al.
Journal of Translational Medicine|August 24, 2010
Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastasesSergio Lavilla-Alonso, Gerd Bauerschmitz, Usama Abo-Ramadan, et al.
Frontiers in Veterinary Science|August 9, 2021
Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow UpSara Saellstrom, Arian Sadeghi, Emma Eriksson, et al.
Gynecologic Oncology|January 22, 2005
Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene deliveryMinghui Wang, Akseli Hemminki, Gene P Siegal, et al.
International Journal of Cancer|June 15, 2017
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapyJoao Manuel Santos, Riikka Havunen, Mikko Siurala, et al.
The Journal of Gene Medicine|April 27, 2011
Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patientsMari Raki, Merja Sarkioja, Sophie Escutenaire, et al.
Human Gene Therapy|October 9, 2013
[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancerAnniina Koski, Helena Ahtinen, Heidi Liljenback, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 13, 2007
Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cellsMinna Eriksson, Kilian Guse, Gerd Bauerschmitz, et al.
Pageof 28

Showing results (151-160 of 280) with videos related to

Sort By:
Pageof 28
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearanceVincenzo Cerullo, Iulia Diaconu, Valentina Romano, et al.
Plos One|January 26, 2013
MicroRNA-mediated suppression of oncolytic adenovirus replication in human liverErkko Ylösmäki, Sergio Lavilla-Alonso, Sari Jäämaa, et al.
Cancer Immunology Research|May 16, 2015
Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the TumorSiri Tähtinen, Susanna Grönberg-Vähä-Koskela, Dave Lumen, et al.
Journal of Translational Medicine|August 24, 2010
Adenoviruses with an αvβ integrin targeting moiety in the fiber shaft or the HI-loop increase tumor specificity without compromising antitumor efficacy in magnetic resonance imaging of colorectal cancer metastasesSergio Lavilla-Alonso, Gerd Bauerschmitz, Usama Abo-Ramadan, et al.
Frontiers in Veterinary Science|August 9, 2021
Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas-Long-Term Follow UpSara Saellstrom, Arian Sadeghi, Emma Eriksson, et al.
Gynecologic Oncology|January 22, 2005
Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene deliveryMinghui Wang, Akseli Hemminki, Gene P Siegal, et al.
International Journal of Cancer|June 15, 2017
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapyJoao Manuel Santos, Riikka Havunen, Mikko Siurala, et al.
The Journal of Gene Medicine|April 27, 2011
Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patientsMari Raki, Merja Sarkioja, Sophie Escutenaire, et al.
Human Gene Therapy|October 9, 2013
[(18)F]-fluorodeoxyglucose positron emission tomography and computed tomography in response evaluation of oncolytic adenovirus treatments of patients with advanced cancerAnniina Koski, Helena Ahtinen, Heidi Liljenback, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 13, 2007
Oncolytic adenoviruses kill breast cancer initiating CD44+CD24-/low cellsMinna Eriksson, Kilian Guse, Gerd Bauerschmitz, et al.
Pageof 28